DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 176 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $252,847,000 | +160.6% | 12,542 | +382.4% | 0.00% | – |
| Q2 2021 | $97,032,000 | -73.1% | 2,600 | -81.6% | 0.00% | -100.0% |
| Q1 2021 | $360,972,000 | -95.2% | 14,117 | -95.8% | 0.00% | -92.9% |
| Q4 2020 | $7,467,884,000 | +248.2% | 338,987 | +184.3% | 0.01% | +366.7% |
| Q3 2020 | $2,144,804,000 | +579.5% | 119,222 | +859.4% | 0.00% | +200.0% |
| Q2 2020 | $315,646,000 | -53.8% | 12,427 | -66.6% | 0.00% | 0.0% |
| Q1 2020 | $682,923,000 | -54.5% | 37,176 | -45.4% | 0.00% | -66.7% |
| Q4 2019 | $1,500,243,000 | +1141.5% | 68,100 | +709.3% | 0.00% | – |
| Q3 2019 | $120,839,000 | +28.4% | 8,415 | +40.9% | 0.00% | – |
| Q2 2019 | $94,075,000 | -42.5% | 5,973 | -46.6% | 0.00% | – |
| Q1 2019 | $163,743,000 | +639.0% | 11,177 | +669.8% | 0.00% | – |
| Q3 2018 | $22,158,000 | +12.6% | 1,452 | -9.6% | 0.00% | – |
| Q2 2018 | $19,674,000 | +6329.4% | 1,606 | +4918.8% | 0.00% | – |
| Q1 2018 | $306,000 | +5.9% | 32 | 0.0% | 0.00% | – |
| Q4 2017 | $289,000 | +57.1% | 32 | 0.0% | 0.00% | – |
| Q3 2017 | $184,000 | +82.2% | 32 | 0.0% | 0.00% | – |
| Q2 2017 | $101,000 | -7.3% | 32 | 0.0% | 0.00% | – |
| Q1 2017 | $109,000 | +18.5% | 32 | 0.0% | 0.00% | – |
| Q4 2016 | $92,000 | -99.8% | 32 | -99.0% | 0.00% | – |
| Q4 2015 | $37,462,000 | +46.1% | 3,156 | +1.0% | 0.00% | – |
| Q3 2015 | $25,648,000 | +46.4% | 3,124 | +148.7% | 0.00% | – |
| Q2 2015 | $17,521,000 | +885.4% | 1,256 | +1597.3% | 0.00% | – |
| Q1 2015 | $1,778,000 | -16.4% | 74 | -55.7% | 0.00% | – |
| Q3 2014 | $2,126,000 | +29.0% | 167 | +128.8% | 0.00% | – |
| Q2 2014 | $1,648,000 | – | 73 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|